The role of pulmonary surfactant in airway obstruction and its influence on airway reopening - review

Kuraszkiewicz, B.

Artykuł - szczegóły

Tytuł artykułu

The role of pulmonary surfactant in airway obstruction and its influence on airway reopening - review

Autorzy

Kuraszkiewicz B.

Wybrane pełne teksty z tego czasopisma

Identyfikatory

Warianty tytułu

Języki publikacji

Abstrakty

Our knowledge about the role of pulmonary surfactant in obstructive airways disease is stiII limited, but there is convincing evidence that pulmonary surfactant plays a role in keeping the airways open. Whereas lung damage with dysfunction of alveolar surfactant is of importance in various respiratory diseases, such as ARDS (adult respiratory distress syndrome) or pneumonia, alveolar surfactant dysfunction does not seem to play a major role in obstructive airways disease. On the contrary, surfactant impairment in the airways as a secondary consequence of airway inflammation might have a major impact on the small airway function. Thus, dysfunction of surfactant in the airways might be a contributory factor to airway obstruction and increased airway resistance in obstructive lung disease. In last years, direct and indirect evidence has emerged for surfactant as a factor in the regulation of airway calibers. Surfactant may be of a greater importance in the airways than it has previously been recognized. This review will discuss those aspects of the airway mechanics that are closely related to the function of pulmonary surfactant. Some of the mechanisms discussed may be of secondary rather than primary importance in obstructive airways disease.

Słowa kluczowe

pulmonary surfactant obstructive airways disease airway reopening

pulmonologia drogi oddechowe choroba dróg oddechowych

Wydawca

Nałęcz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences
Elsevier

Czasopismo

Biocybernetics and Biomedical Engineering

Rocznik

2006

Tom

Vol. 26, no. 2

Strony

75--83

Opis fizyczny

Bibliogr. 60 poz., rys.

Twórcy

autor

Kuraszkiewicz B.

Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Ks. J. Trojdena 4, 02-109 Warsaw, Poland, bozena@ibib.waw.pl

Bibliografia

1. Hamm H., Kroegel C., Hohlfeld J.: Surfactant. Respir. Med., 1996, 90, 251-270.
2. Dobbs L.G.: Pulmonary surfactant. Annu.Rev.Med., 1998, 40, 431-446.
3. Avery M.E., Mead J.: Surface properties in relation to atelectasis and hyaline membrane disease, Am. J. Dis. Child, 1959, 97, 517-523.
4. Gunther A., Siebert C., Schmidt R., et al.: Surfactant alternations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung oedema. Am. J. Respir. Crit. Care Med., 1996, 153(1), 176-184.
5. van de Graaf E.A., Jansen H.M., Lutter R. et al.: Surfactant protein A in bronchoalveolar lavage fluid. J. Lab. Clin. Med.,1992, 120, 252-263.
6. doCampo J.L., Bertranou E.G., Casellas A., Bonatto P., Battellini R.: Pulmonary surfactant post cardiac surgery with cardiopulmonary bypass. Am. Rev. Respir. Dis., 1990, 141(Suppl.), A512.
7. McGowan F.X., Ikegami M., del Nido P.J.: Cardiopulmonary bypass significantly reduces surfactant activity in children. J. Thorac. Cardiovasc. Surg., 1993, 106(6), 968-977.
8. Bos J.H., Lachmann B.: Effects of artificial ventilation on surfactant function. In: Rugheimer E. Ed. New Aspects on Respiratory Failure. Berlin, Heidelberg, New York, Springer, 1992, 194-208.
9. Hohlfeld J., Tschorn H., Tiryaki E.: Surfactant protein A (SP-A) alternations in bronchoalveolar lavage of lung transplant patients. Appl. Cardiopulm. Pathophysiol., 1995, 5(Suppl.), 59-61.
10. Kurashima K., Ogawa H., Ohka T., Matsuda T., Kobayshi T.: A pilot study of surfactant inhalation in the treatment of asthmatic attact. Jpn. J. Allergol., 2001, 40(2), 160-163.
11. Gregory T.J., Gadek J.E., Weiland J.E.: Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med., 1994, 149(4/2), A567.
12. Walmrath D., Gunther A., Ghofrani H.: Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis, Am. J. Respir. Crit. Care Med., 2001, 154, 57-62.
13. Hamm H., Fabel H., Bartsch W.: The surfactant system of the adult lung: physiology and clinical perspectives. Clinical Invest., 2002, 70, 637-657.
14. Mason R.J.: Surfactant synthesis, secretion, and function in alveoli and small airways. Respiration, 1997, 51(Suppl.1), 3-9.
15. Auten R.L., Watkins R.H., Shapiro D.L., Horowitz S.: Surfactant apoprotein A is synthetized in airway cells. Am. J. Respir., 1999, 3, 491-496.
16. Crouch E., Rust K., Marienchek W., Parghi D., Chang D., Persson A.: Developmental expression of pulmonary surfactant protein D. Am. J. Respir., 2001, 5, 13-18.
17. Wohlford-Lenane C.L., Snyder J.M.: Localization of surfactant associated proteins in rabbit fetal tissue by in situ hybridization. Am. J. Respir., 2002, 7, 335-343.
18. Girod S., Fuchey C., Galabert C. Et al.: Identification of phospholipids in secretory granules of human submucosal gland respiratory cells. Respir. Physiol., 2001, 39, 193-203.
19. van Golde L.M.C., Batenburg J.J, Robertson B.: The pulmonary surfactant system: biochemical aspects and functional significance. Physiol.Rev., 1998, 68, 374-455.
20. Rich E.A.: Pulmonary surfactant as a physiologic immunosuppressive agent. J. Lab. Clin. Med., 2000, 116, 4.
21. Haagsman H.P., van Golde L.M.: Synthesis and assembly of lung surfactant. Annu. Rev. Physiol., 1999, 53, 441-464.
22. Mecklem P.T., Hogg J.C.: The stability of peripheral airways. Respir. Physiol., 1990, 88, 191-203.
23. Otis D.R., Johnson M., Pedley T.J., Kamm R.D.: Role of pulmonary surfactant in airway closure: a computational study. J. Appl. Physiol., 1993, 75, 1323-1333.
24. Kamm R.D., Schroter R.C.: Is airway closure caused by liquid film instability? Respir. Physiol., 2003, 75(2), 141-156.
25. Gaver D.P., Samsel R.W., Solway J.: Effects of surface tension and viscosity on airway reopening. J. Appl. Physiol., 1999, 69, 74-85.
26. Enhorning G., Holm B.A.: Disruption of pulmonary surfactants ability to maintain openness of a narrow tube. J. Appl. Physiol., 1998, 74(6), 2922-2927.
27. Bredenberg C.E., Paskanik A.M., Nieman G.F.: High surface tension pulmonary edema. J. Surg. Respir., 2003, 64, 515-523.
28. Schurch S., Gehr P., Im Holf V., Geiser M., Green F.: Surfactant displaces particles toward the epithelium in airways and alveoli. Respir. Physiol., 1999, 80(1), 17-32.
29. Morgenroth K., Bolz J.: Morphological features of the interaction between mucus and surfactant in the bronchial mucosa. Respiration, 2002, 47, 225-231.
30. Gehr P., Geiser M., Schurch S., Waber U., Baumann M.: Surfactant and inhaled particles in the conducting airways. Microsc. Res. Tech., 1998, 26, 423-436.
31. Kakuta Y., Sasaki H., Takishima T.: Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol., 1999, 83, 313-322.
32. Catanzano A., Richman P., Batcher S. Hallman M.: Immunomodulation by pulmonary surfactant. J. Lab. Clin. Med., 2001, 112, 727-734.
33. van Iwaarden J.F.: Surfactant and pulmonary defense system. In: Robertson B., van Golde L.M.G., Batenburg J.J., eds., Pulmonary surfactant: From Molecular Biology to Clinical Practice. Amsterdam, London, New York, Tokyo, Elsevier, 1992, 215-227.
34. van Iwaarden J.F., Welmers P., Verfoef J., Haagsman H.P.: Pulmonary surfactant protein enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Biol., 2000, 2, 91-98.
35. Hills B.A.: Asthma: is there an airway receptor barrier? Thorax, 2001, 51, 773-776.
36. Bergmann J., Schnitzler S., Seidel M., Lachmann B.: Suppression of angiotensin II-included contraction of the isolated guinea pig ileum by alveolar surfactants. Pneumologie, 2003, 48 (Suppl.2), 328.
37. Hohlfeld J., Molthan J., Hoyhmann H.G., Fabel H., Heinrich U.: Pneumologie, 1999, 48, 623.
38. Hohlfeld J., Molthan J., Hoyhmann H.G., Fabel H., Heinrich U.: Aerosolized surfactant inhibits acetylocholine induced bronchoconstriction in rates in vivo. Am. J. Respir. Crit. Care Med., 1999, 149(4/2).
39. So K.L., Lachmann B.: Bronchoalveolar surfactant and intratracheal aline. Lancet, 2001, 341, 120-132.
40. Wiggs B.R., Bosken C., Pare P.D., James A., Hogg J.C.: A model of airway narrowing in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 2002, 145, 1251-1258.
41. Brusasco V., Pellegrino R., Violante B.: Relationship between quasi-static pulmonary hysteresis and maximal airway narrowing in humans. J. Appl. Physiol., 2002, 72, 2075-2080.
42. Yager D., Kamm R.D., Drazen J.M.: Airway wall liquid: sources and role as an amplifier of bronchoconstriction. Chest, 1995, 107 Suppl. 3, 1058-1108.
43. Yager D., Butler J.P., Bastacky J., Israel E., Smith G., Drazen J.: Amplification of airway constriction due to liquid filling of airway interstices. J. Appl. Physiol., 2002, 84, 2873-2884.
44. Enhoring B., Duffy L.C., Welliver R.C.: Pulmonary surfactant maintains patency of conducting airways in the rat. Am. J. Respir. Crit. Care Med., 2003, 151, 554-556.
45. Ikegami M., Jobe A., Jacobs H., Lam R.: A protein from airways of premature lambs that inhibits surfactant function. J. Appl. Physiol., 2004, 97, 1134-1142.
46. Seeger W., Stohr G., Wolf H.R.D., Neufof H.: Alternation of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol., 1998, 78, 326-338.
47. Fachimukai T., Fujiwara T., Takahashi A., Enhorning G.: Artificial pulmonary surfactant inhibited by proteins. J. Appl. Physiol., 1987, 62, 429-437.
48. Postle A.D.: Lung surfactants and asthma. Clin. Exp. Allergy, 1995, 25, 1030-1033.
49. Liu M., Wang L., Enhorning G.: Surfactant dysfunction develops when the immunized guinea pig is challenged with ovalbumin aerosol. Clin. Exp. Allergy, 1995, 25, 1053-1060.
50. Lemarchand P., Chinet T., Collignon M.A.: Bronchial clearance is increased in acute asthma but not in chronic asthma. Am. Rev. Respir. Dis., 2002, 145, 147-153.
51. Liu M., Wang L., Li E., Enhorning G.: Pulmonary surfactant given prophylactically alleviates an asthma attact in guinea pigs. Clin. Exp. Allergy, 1996, 26, 270-275.
52. Bachofen H., Hildebrandt J., Bachofen M.: Presure-volume curves of air and liquid filled excised lungs: surface tension in situ. J. Appl. Physiol., 1970, 29, 422-431.
53. Wilson T.A., Bachofen H.: A model for mechanical structure of the alveolar duct. J. Appl. Physiol., Respirat. Environ. Exercise Physiol., 1992, 52, 1064-1070.
54. Hyatt R.E., Rodarte J.R., Wilson T.A., Lambert R.K.: Mechanisms of expiratory flow limitation. Ann. Biomed. Eng., 1981, 9, 489-499.
55 Wirtz H.R., Dobbs L.G.: Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science, 1990, 250 (4985), 1266-1269.
56. Frose A.B., McCulloch P.R., Sugiura M., Vaclavik S., Possmayer F., Moller F.: Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am. Rev. Respir. Dis., 2003, 148 (3), 569-577.
57. Wirtz H., Schmidt M.: Ventilation and secretion of pulmonary surfactant. Clin. Invest., 2002, 70, 3-13.
58. Finley T.N., Ladman A.J.: Low yield of pulmonary surfactant in cigarette smokers. Engl. J. Med., 1997, 289, 223-227.
59. Low R.B., Davis G.S., Giancola M.S.: Biochemical analysis of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am. Rev. Respir. Dis., 2000, 118, 863-875.
60. Higenbottam T.: Lung lipids and disease. Respiration, 1989, 55 (Suppl.1), 14-27.

Typ dokumentu

Bibliografia

Identyfikator YADDA

bwmeta1.element.baztech-article-BPZ1-0030-0017